Bert F Bernard
Bone marrow dosimetry in peptide receptor radionuclide therapy with [177Lu-DOTA(0),Tyr(3)]octreotate
Forrer F, de Herder W, van Lom K, de Jong M, Teunissen J, Bakker W, Konijnenberg M, Bernard B, Kooij P, Krenning E, Kwekkeboom D. Bone marrow dosimetry in peptide receptor radionuclide therapy with [177Lu-DOTA(0),Tyr(3)]octreotate. Eur J Nucl Med Mol Imaging 2009; 36:1138-46.
Feb 27, 2009Bone marrow dosimetry in peptide receptor radionuclide therapy with [177Lu-DOTA(0),Tyr(3)]octreotate
Feb 27, 2009Eur J Nucl Med Mol Imaging 2009; 36:1138-46
Forrer Flavio, de Herder Wouter W, van Lom Kirsten, de Jong Marion, Teunissen Jaap J M, Bakker Willem H, Konijnenberg Mark, Bernard Bert F, Kooij Peter P, Krenning Eric P, Kwekkeboom Dik J
Diagnostic versus therapeutic doses of [(177)Lu-DOTA-Tyr(3)]-octreotate: uptake and dosimetry in somatostatin receptor-positive tumors and normal organs
Müller C, Forrer F, Bernard B, Melis M, Konijnenberg M, Krenning E, de Jong M. Diagnostic versus therapeutic doses of [(177)Lu-DOTA-Tyr(3)]-octreotate: uptake and dosimetry in somatostatin receptor-positive tumors and normal organs. Cancer Biother Radiopharm 2007; 22:151-9.
Feb 1, 2007Diagnostic versus therapeutic doses of [(177)Lu-DOTA-Tyr(3)]-octreotate: uptake and dosimetry in somatostatin receptor-positive tumors and normal organs
Feb 1, 2007Cancer Biother Radiopharm 2007; 22:151-9
Müller Cristina, Forrer Flavio, Bernard Bert F, Melis Marleen, Konijnenberg Mark, Krenning Eric P, de Jong Marion